Merav Bassan - Mar 29, 2022 Form 4 Insider Report for BiomX Inc. (PHGE)

Role
Chief Development Officer
Signature
/s/ Merav Bassan
Stock symbol
PHGE
Transactions as of
Mar 29, 2022
Transactions value $
$0
Form type
4
Date filed
3/31/2022, 05:31 PM
Next filing
Aug 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHGE Common Stock Options - Right to Buy Award $0 +100K $0.00 100K Mar 29, 2022 Common Stock 100K $1.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 29, 2023, and the remainder vesting in 12 equal quarterly installments over three years.